
News
Home>News & Events>Publications>C-Path>Challenges and Opportunities to Enhance Global Drug Development in Neonates
86,118
Related Posts
-
Regulatory Science in Neonates: A Framework That Supports Evidence-Based Drug Therapy
-
Safety, Dosing, and Pharmaceutical Quality for Studies That Evaluate Medicinal Products (Including Biological Products) in Neonates
-
The International Neonatal Consortium: Collaborating to Advance Regulatory Science for Neonates
-
Global Collaboration to Develop New and Existing Drugs for Neonates
-
Global Efforts to Accelerate the Development of Safe and Efficacious Therapies for Newborns